Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors
NCT 04450732 Brief Summary Phase I Dose Finding Study for GQ1001 in…
Read more arrow_forwardNCT 04450732 Brief Summary Phase I Dose Finding Study for GQ1001 in…
Read more arrow_forwardNCT 05614258 Brief Summary ADG206 is an activatable prodrug form of a…
Read more arrow_forwardNCT 05919537 Brief Summary This is a phase 1b multi-center, open-label study…
Read more arrow_forwardNCT 05267626 Brief Summary This is a first in human, open-label, multi-center…
Read more arrow_forwardNCT 04644068 Brief Summary This research is designed to determine if experimental…
Read more arrow_forwardNCT 03947385 Brief Summary This is a Phase 1/2, multi-center, open-label basket…
Read more arrow_forwardNCT 05199753 Brief Summary This is a first-in-human, Phase I/II, open-label, multi-centre,…
Read more arrow_forwardNCT 02628067 Brief Summary In this study, participants with multiple types of…
Read more arrow_forwardNCT 03821935 Brief Summary The study will determine the recommended Phase 2…
Read more arrow_forwardNCT 04665206 Brief Summary This is an open-label, dose escalation and expansion…
Read more arrow_forward